![Elaine Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elaine Sullivan
Directeur/Membre du Conseil chez
HVIVO PLC
Fortune : 233 615 $ au 31/07/2026
Profil
Elaine Sullivan was the founder of Carrick Therapeutics, Inc., founded in 2015, serving as Chief Executive Officer from 2015 to 2019.
Dr. Sullivan was the founder of Curadh Pharmaceuticals Ltd., founded in 2020, serving as Chief Executive Officer.
Dr. Sullivan is also the founder of Carrick Therapeutics Ltd...
Dr. Sullivan is a Non-Executive Director at Pharming Group NV since 2025.
Dr. Sullivan is a Senior Independent Non-Executive Director at hVIVO PLC since 2025.
Dr. Sullivan is a Non-Executive Director at Zealand Pharma A since 2024.
Dr. Sullivan was Chief Executive Officer at Keltic Pharma Therapeutics Ltd. from 2021 to 2023.
Dr. Sullivan was Non-Executive Director at hVIVO Holdings Ltd. from 2020 to 2023.
Dr. Sullivan was Independent Director at Active Biotech AB. Dr. Sullivan was Non Executive Director at IP Group Plc.
Dr. Sullivan was Independent Non-Executive Director at IP Group Plc from 2015 to 2024.
Dr. Sullivan was Non-Executive Director at Nykode Therapeutics ASA from 2022 to 2025.
Dr. Sullivan was Vice President-Research & Development at AstraZeneca PLC from 1995 to 2010.
Dr. Sullivan was VP-Global External Research & Development at Eli Lilly & Co. from 2011 to 2015.
Dr. Sullivan was Member-Supervisory Board at Evotec SE from 2015 to 2024.
Dr. Sullivan completed an undergraduate degree at the University of Glasgow in 1983.
Dr. Sullivan earned a doctorate from The University of Edinburgh in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Oxford Metrics Plc
 Oxford Metrics Plc Electronic Equipment/InstrumentsElectronic Technology Engages in development, production and sale of computer software & equipment for the engineering, entertainment and life science markets 0,23 % | 17/06/2026 | 260 000 ( 0,23 % ) | 133 661 $ | 31/07/2026 |
PHARMING GROUP NV 0,01 % | 28/05/2026 | 59 746 ( 0,01 % ) | 60 368 $ | 31/07/2026 |
| 31/12/2025 | 846 ( 0 % ) | 39 587 $ | 31/07/2026 |
Postes actifs de Elaine Sullivan
| Sociétés | Poste | Début |
|---|---|---|
| HVIVO PLC | Directeur/Membre du Conseil | 01/09/2025 |
| ZEALAND PHARMA A/S | Directeur/Membre du Conseil | 20/03/2024 |
| PHARMING GROUP N.V. | Directeur/Membre du Conseil | 11/06/2025 |
Anciens postes connus de Elaine Sullivan
| Sociétés | Poste | Fin |
|---|---|---|
| NYKODE THERAPEUTICS | Directeur/Membre du Conseil | 23/04/2025 |
| IP GROUP PLC | Directeur/Membre du Conseil | 12/06/2024 |
| EVOTEC SE | Directeur/Membre du Conseil | 10/06/2024 |
Keltic Pharma Therapeutics Ltd.
 Keltic Pharma Therapeutics Ltd. BiotechnologyHealth Technology Engages in drug discovery programs | Directeur Général | 01/05/2023 |
| HVIVO PLC | Directeur/Membre du Conseil | 01/05/2023 |
Formation de Elaine Sullivan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
hVIVO Holdings Ltd.
 hVIVO Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IP Group Plc
 IP Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as an intellectual property commercialization and venture capital fund management company | Commercial Services |
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
IP Group Plc /Venture Capital/
 IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group invests in companies located in the United Kingdom, United States and Australia. The firm targets companies operating in the fileds of life sciences, deeptech and cleantech. It provides financing for early stage capital requirements. | Finance |
Carrick Therapeutics Ltd.
 Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for oncological therapy treatment | Health Technology |
hVIVO PLC
 hVIVO PLC Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical development services | Commercial Services |
Curadh Pharmaceuticals Ltd. | |
Keltic Pharma Therapeutics Ltd.
Keltic Pharma Therapeutics Ltd. BiotechnologyHealth Technology Engages in drug discovery programs | Health Technology |
